tolvaptan has been researched along with Polyuria in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, L; Gong, L; Jiang, W; Lu, J; Qian, X; Tang, W; Xie, F; Xu, M; Xu, W | 1 |
| Hirose, T; Ito, S; Kinugasa, S; Mori, T; Muroya, Y; Oba-Yabana, I; Ohsaki, Y; Sato, E; Takahashi, C; Wang, A | 1 |
| Boertien, WE; Gansevoort, RT; Kramers, BJ; Meijer, E; van Gastel, MDA | 1 |
| Emoto, M; Fujimoto, K; Inaba, M; Ishimura, E; Machiba, Y; Mori, K; Nakatani, A; Nakatani, S; Okute, Y; Tsuda, A; Uedono, H | 1 |
| Bae, KT; Casteleijn, NF; Higashihara, E; Kappert, P; Leliveld, AM; Meijer, E; Messchendorp, AL; Torres, V | 1 |
| Cho, C; Lien, YH; Logan, JL | 1 |
1 review(s) available for tolvaptan and Polyuria
| Article | Year |
|---|---|
Efficacy and safety of tolvaptan versus placebo in the treatment of patients with autosomal dominant polycystic kidney disease: a meta-analysis.
Topics: Abdominal Pain; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Hematuria; Humans; Hypertension; Polycystic Kidney, Autosomal Dominant; Polyuria; Tolvaptan | 2023 |
2 trial(s) available for tolvaptan and Polyuria
| Article | Year |
|---|---|
Determinants of Urine Volume in ADPKD Patients Using the Vasopressin V2 Receptor Antagonist Tolvaptan.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Female; Humans; Male; Middle Aged; Polycystic Kidney, Autosomal Dominant; Polyuria; Prospective Studies; Tolvaptan | 2019 |
Polyuria due to vasopressin V2 receptor antagonism is not associated with increased ureter diameter in ADPKD patients.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Netherlands; Polycystic Kidney, Autosomal Dominant; Polyuria; Receptors, Vasopressin; Risk Factors; Time Factors; Tolvaptan; Treatment Outcome; Ureter; Urodynamics | 2017 |
3 other study(ies) available for tolvaptan and Polyuria
| Article | Year |
|---|---|
Hydrochlorothiazide ameliorates polyuria caused by tolvaptan treatment of polycystic kidney disease in PCK rats.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Blood Pressure; Diuretics; Drug Therapy, Combination; Gene Expression; Glomerular Filtration Rate; Hydrochlorothiazide; Male; Nitric Oxide Synthase Type I; Polycystic Kidney Diseases; Polyuria; Prostaglandin-E Synthases; Rats; Renin; RNA, Messenger; Tolvaptan; Urine | 2019 |
Novel increasing dose regimen of tolvaptan for autosomal dominant polycystic kidney disease in patient with low tolerability.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Polycystic Kidney, Autosomal Dominant; Polyuria; Tolvaptan; Treatment Outcome | 2018 |
Massive aquaresis after tolvaptan administration and albumin infusion in a patient with alcoholic cirrhosis.
Topics: Adult; Albumins; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Infusions, Intravenous; Liver Cirrhosis, Alcoholic; Male; Polyuria; Tolvaptan | 2012 |